Aug 24, 2026 04:00PM
Aug 14, 2026 07:54AM
Aug 14, 2026 06:38AM
Aug 12, 2026 09:45PM
Aug 12, 2026 07:59AM
Aug 12, 2026 07:23AM
Aug 11, 2026 04:01PM FDA grants priority review to Belite Bio's Stargardt disease drug
Aug 11, 2026 04:01PM
Jul 20, 2026 08:00AM
Jul 20, 2026 08:00AM
Jun 16, 2026 06:44AM
Jun 15, 2026 03:02AM
Jun 12, 2026 09:30PM
May 22, 2026 09:33AM Benchmark Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)
May 21, 2026 06:38AM
May 20, 2026 06:00AM
May 18, 2026 04:00PM
May 18, 2026 04:00PM
May 15, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 22, 2026 08:35AM Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th
Apr 21, 2026 04:00PM
Apr 21, 2026 04:00PM
Apr 13, 2026 06:38AM
Apr 7, 2026 07:46AM
Mar 4, 2026 08:42AM
Mar 4, 2026 06:42AM
Mar 3, 2026 09:37AM Belite Bio, Inc, ADR (BLTE) PT Raised to $217 at Benchmark Following Business Update
Mar 2, 2026 06:00AM
Jan 29, 2026 08:00AM
Jan 27, 2026 08:04AM
Jan 27, 2026 08:00AM
Jan 26, 2026 06:12AM
Dec 3, 2025 08:44AM
Dec 1, 2025 06:00AM Belite Bio reports positive phase 3 results for Stargardt disease drug
Dec 1, 2025 06:00AM
Nov 10, 2025 08:00AM
Sep 15, 2025 07:28AM
Sep 10, 2025 08:51AM
Aug 12, 2025 09:42AM
Aug 11, 2025 06:00AM
Jul 2, 2025 03:00AM Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
May 22, 2025 08:39AM
May 21, 2025 03:00AM
May 15, 2025 09:10AM
May 15, 2025 07:23AM
May 13, 2025 09:00PM
Apr 29, 2025 08:00AM
Mar 17, 2025 06:00AM Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Nov 27, 2024 03:00AM

329,910 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All